Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132291) titled 'Research on the Prediction Model of Remimazolam Anesthesia Induction Dose Based on Multi-modal Fusion Data-Driven Machine Learning Algorithms' on Sept. 11.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: The General Hospital of the Central Theater Command

Condition: None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-30

Target Sample Size: The observation group of remimazolam anesthesia induction dose:400;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=341993

Disclaimer: Curated by HT Synd...